Biomedicines (Apr 2022)

Metformin Protects against Diabetic Cardiomyopathy: An Association between Desmin–Sarcomere Injury and the iNOS/mTOR/TIMP-1 Fibrosis Axis

  • Amal F. Dawood,
  • Norah M. Alzamil,
  • Peter W. Hewett,
  • Maha A. Momenah,
  • Mohammad Dallak,
  • Samaa S. Kamar,
  • Dina H. Abdel Kader,
  • Hanaa Yassin,
  • Mohamed A. Haidara,
  • Amro Maarouf,
  • Bahjat Al-Ani

DOI
https://doi.org/10.3390/biomedicines10050984
Journal volume & issue
Vol. 10, no. 5
p. 984

Abstract

Read online

The intermediate filament protein desmin is essential for maintaining the structural integrity of sarcomeres, the fundamental unit of cardiac muscle. Diabetes mellitus (DM) can cause desmin to become dysregulated, following episodes of nitrosative stress, through the activation of the iNOS/mTOR/TIMP-1 pathway, thereby stimulating collagen deposition in the myocardium. In this study, type 2 diabetes mellitus (T2DM) was induced in rats. One group of animals was pre-treated with metformin (200 mg/kg) prior to diabetes induction and subsequently kept on metformin until sacrifice at week 12. Cardiac injuries developed in the diabetic rats as demonstrated by a significant (p p < 0.0001) correlation between desmin tissue levels/sarcomere damage and glycated hemoglobin, heart rate, iNOS, mTOR, and fibrosis was observed. These findings demonstrate an association between damage of the cardiac contractile unit—desmin and sarcomere—and the iNOS/mTOR/TIMP-1/collagen axis of fibrosis in T2DM-induced cardiomyopathy, with metformin exhibiting beneficial cardiovascular pleiotropic effects.

Keywords